PRIMAXIN IV

Imipenem and cilastatin sodium · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for PRIMAXIN IV, covering 2006-08-04 to 2022-01-30. Get the full timeline:

Most recent: FDA Approved: PRIMAXIN IV — Supplemental Application (Merck Sharp & Dohme LLC)